Investigation of USP30 inhibition to enhance Parkin-mediated mitophagy: tools and approaches
Ketteler, R.; Tsefou, E.; Walker, A. S.; Clark, E. H.; Hicks, A. R.; Luft, C.; Takeda, K.; Watanabe, T.; Ramazio, B.; Staddon, J. M.; Briston, T.
Show abstract
Mitochondrial dysfunction is implicated in Parkinson disease (PD). Mutations in Parkin, an E3 ubiquitin ligase, can cause juvenile-onset Parkinsonism probably through impairment of mitophagy. Inhibition of the de-ubiquitinating enzyme USP30 may counter this effect to enhance mitophagy. Using different tools and cellular approaches, we wanted to independently confirm this claimed role for USP30. Pharmacological characterization of additional tool compounds that selectively inhibit USP30 are reported. The consequence of USP30 inhibition by these compounds, siRNA knockdown and overexpression of dominant-negative USP30 in the mitophagy pathway in different disease-relevant cellular models was explored. Knockdown and inhibition of USP30 showed increased p-Ser65-ubiquitin levels and mitophagy in neuronal cell models. Furthermore, patient-derived fibroblasts carrying pathogenic mutations in Parkin showed reduced p-Ser65-ubiquitin levels compared to wild-type cells, levels that could be restored using either USP30 inhibitor or dominant-negative USP30 expression. Our data provide additional support for USP30 inhibition as a regulator of the mitophagy pathway.
Matching journals
The top 13 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Pharmacological rescue of impaired mitophagy in Parkinson's disease-related LRRK2 G2019S knock-in mice 96%
- Identification of novel autophagy inducers by accelerating lysosomal clustering against Parkinson's disease 95%
- DBT is a metabolic switch for maintenance of proteostasis under proteasomal impairment 94%
Similar papers in this journal
- The activities of LRRK2 and GCase are positively correlated in clinical biospecimens and experimental models of Parkinson's disease 95%
- Parkin is not required to sustain OXPHOS function in adult mammalian tissues 94%
- High Content Screening and Proteomic Analysis Identify a Kinase Inhibitor that rescuespathological phenotypes in a Patient-Derived Model of Parkinson's Disease 94%
Similar papers in this journal
- The eIF2α kinase HRI triggers the autophagic clearance of cytosolic protein aggregates 94%
- Intra-mitochondrial proteostasis is directly coupled to alpha-synuclein and Amyloid β 1-42 pathology 93%
- Distinct alpha-synuclein strains derived from Parkinson's disease patient tissues trigger differential inclusion pathology in a novel biosensor cell model 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.